A radical plan by a former Trump aide seeks to encourage obese Americans to lose weight—by helping their wallet. Robert P.
Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...
Diet Coke is having a moment as the drink of choice for Donald Trump, but daily consumption may carry risks, including ...
AdvaMed, the largest medical device association globally, urged the Trump administration to exempt medical products from the ...
Mark Zuckerberg’s Meta will pay roughly $25 million to settle a 2021 lawsuit brought by President Donald Trump, who accused ... But Meta arguably had more to lose by winning this one.
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion.